Big Blog

Arts & Culture
Banking
Biological Science
Blog Watch
Celebrities
Computer Games
Computer Security
Cricket
Data Privacy
Developer
Domain Names
E-commerce
Gadgets
General Science
Handhelds
IP & Patents
Java
Linux
Mobile Technology
Movie Reviews
MP3
Nanotech
Online Auctions
Online Legal Issues
Open Source
Personal Finance
Photography
Quirky
Robotics
Search Engines
Space Science
Top Internet
Top Stories
Top Tech
Video Games
Web Developer
Webmaster Tips
XML & Metadata
{Home}



diseases: search

O2 Public Relations and UAE Genetic Diseases Association enter into a Strategic Partnership

The UAE Genetic Diseases Association (UAEGDA) has signed an agreement with O2 Public Relations to develop long-term strategic communications and marketing campaigns. This comes in support of the National Health campaign ‘Emirates Free of Thalassemia by 2012’ – the first project of UAE Genetic Diseases Association (UAEGDA) established under the patronage of H.H. Sheikh Nahyan Bin Mubarak Al Nahyan, Minister of Higher Education and Scientific Research, UAE. In line with the UAE federal government's vision to make the country free from new births of children with Thalassemia disease by the year 2012, H.E. Dr. Maryam Matar, Executive Director of the UAE Genetic Diseases Association (UAEGDA) has welcomed the support of O2 Public Relations in reaffirming its commitment to raising awareness and reducing the impact of common inherited blood

Why Are So Many Infectious Diseases Jumping From Animals To Humans?

Why are so many infectious diseases jumping from animals to humans? Why do we have so little capacity to predict epidemics, or avoid them? Some answers, and possible solutions, can be found in the first trench-to-bench guide to wild primate infectious diseases, to be published Nov. 17 in the Yearbook of Physical Anthropology.

OHSU finds association between Epstein-Barr virus, inflammatory diseases of the mouth

Researchers at Oregon Health & Science University's School of Dentistry have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus. The Epstein-Barr virus is an important human pathogen found in more than 90 percent of the world population. It is associated with many diseases, including infectious mononucleosis, malignant lymphomas, and naspharyngeal carcinoma.

Mobile phones can help manage diseases

Mobile phones are reaching people across Africa more rapidly than anywhere else in the world, say Richard Lester and Sarah Karanja. And they can be used to help manage diseases such as HIV/AIDS, provide support during political crises and improve health services.

CytoDyn Awarded Global Patents For Modernizing Treatment of Infectious Diseases

(RTTNews) - CytoDyn Awarded Global Patents For Modernizing Treatment of Infectious Diseases

Othera Pharmaceuticals Announces First U.S. Patent Issued On New Class of Compounds to Treat AMD and Other Ophthalmic Diseases

Othera Pharmaceuticals Announces First U.S. Patent Issued On New Class of Compounds to Treat AMD and Other Ophthalmic Diseases

Othera Pharmaceuticals Announces First U.S. Patent Issued On New Class of Compounds to Treat AMD and Other Ophthalmic Diseases

EXTON, Pa.--(BUSINESS WIRE)--Oct 28, 2008 - Othera Pharmaceuticals, Inc., a specialty pharmaceuticals company focused on novel, patient-administered products for ophthalmic disease, has today announced the U.S. Patent and Trademark Office (PTO) issued to Othera the first patent covering a broad class of disubstituted hydroxylamine small molecules that target oxidative stress and inflammation pathways believed to be involved in age-related macular degeneration (AMD) and other diseases of the eye. U.S. Patent No. 7,442,711 covers several new chemical entities, including composition of matter and use of the company's lead product candidate, OT-551. David Joseph, Othera's Chairman and CEO, commented, "We are quite pleased that the PTO has issued this important patent to protect our OT-551 intellectual property estate.

New TB Drug Destroys Bacteria from the Inside

Scientists from the National Institute of Allergy and Infectious Diseases (NIAID) – a part of the National Institutes of Health (NIH) – working with colleagues from the Novartis Institute for Tropical Diseases in Singapore, managed to devise a new experimental drug, that showed promise in lab tests, when it managed to make Mycobacterium Tuberculosis, the bacterium that triggers tuberculosis (TB), explode from within, after the medicine forced it to secrete nitric oxide (NO).

How 'digital diseases' are damaging e-retailers

The Wise Marketer - the web site for news, research, and information about customer loyalty, customer retention, and customer relationship marketing. From daily marketing news and briefings to articles, book reviews, we offer unbiased news and information for marketing executives and researchers who want to know about customer loyalty, CRM, customer lifetime value, win-back, customer retention, and customer acquisition.

New Nano Biosensor Device to Revolutionise Diseases Identification

Zetasizer Nano ZS – Particle Size Analysis, Zeta Potential and Molecular Weight Measurement – Malvern Instruments

CNSE Professor Using Nanotechnology to Address Human Diseases

Add our nanotechnology news to del.icio.us Add our nanotechnology news to digg Add our nanotechnology news to NewsVine Add our nanotechnology news to Furl Add our nanotechnology news to YahooMyWeb Add our nanotechnology news to Reddit - Add our nanotechnology news to StumbleUpon - Add our nanotechnology news to Facebook -

Systems Biology And Glycomics Applied To Study Of Human Inflammatory Diseases

An innovative systems biology approach to understanding the carbohydrate structures in cells is leading to new ways to understand how inflammatory illnesses and cardiovascular disease develop in humans. The work was described in two recent publications by University at Buffalo chemical engineers.

CytoDyn Awarded Global Patents For Modernizing The Treatment of Infectious Diseases

SANTA FE, N.M.--(BUSINESS WIRE)--Dec 3, 2008 - CytoDyn, Inc. (Pink Sheets:CYDY) has rounded out its European patent portfolio with new patents in Ireland, France, Switzerland, Austria, Luxembourg, Netherlands, and Germany. The Company is also receiving new patents in Hong Kong and Canada.

CytoDyn Awarded Global Patents For Modernizing The Treatment of Infectious Diseases

CytoDyn, Inc. (Pink Sheets:CYDY) has rounded out its European patent portfolio with new patents in Ireland, France, Switzerland, Austria, Luxembourg, Netherlands, and Germany. The Company is also receiving new patents in Hong Kong and Canada.

Induction Of Pgc-1 Alpha Expression In Huntington's Disease Transgenic Mice Rescues Neuronal Dysfunction And Neurodegeneration

Neurodegenerative diseases pose a considerable burden to our aging population. Huntington's disease (HD) is an inherited neurological disorder that affects as many as 40,000 people in the U.S. alone. HD causes degeneration of the brain, which results in involuntary movement disorder, cognitive decline, and ultimately death.

New EU directive could lead to worrying restrictions on vital research, claim scientists

Vital research into degenerative diseases such as Alzheimer's could be severely restricted by a new European law on animal testing, claim scientists.

Scientists demonstrate mammal extinction due to disease

Scientists have claimed that diseases carried by Eurasian black rats caused the rapid extinction of Christmas Island native rats - the first study to demonstrate extinction in a mammal because of disease.

Robotic heart surgery ray of new hope : Dr Ravi Kumar

''With increasing stress levels, lifestyle diseases, including heart ailments, are on the rise and robot -assisted surgery promises a way out,'' said Dr Ravi Kumar, Director, Institute of Cardio-Vascular disease and Robotic Surgery Centre, Chettinad Health city (CHC), Chennai.

Robotic heart surgery ray of new hope : Dr Ravi Kumar

Kolkata, Nov 21 : 'With increasing stress levels, lifestyle diseases, including heart ailments, are on the rise and robot -assisted surgery promises a way out,' said Dr Ravi Kumar, Director, Institute of Cardio-Vascular disease and Robotic Surgery Centre, Chettinad Health city (CHC), Chennai.


Search News:


Copyright © 2001-2008 Jonathan Hedley